載入...
Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
COVID-19 represents a new potentially life-threatening illness caused by severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 pathogen. In 2021, new variants of the virus with multiple key mutations have emerged, such as B.1.1.7, B.1.351, P.1 and B.1.617, and are threatening to render avail...
Na minha lista:
| 發表在: | Molecules |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8158358/ https://ncbi.nlm.nih.gov/pubmed/34070140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26103003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|